Search Results

Displaying Results 1-25 of 190 "'BK'"

Apr 03, 2026, 17:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Apr 03, 2026, 17:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Apr 02, 2026, 09:00 ET BNY 2026 Annual Meeting of Stockholders

YORK, April 2, 2026 /PRNewswire/ -- As previously announced, The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, will hold the 2026 Annual Meeting of Stockholders on Tuesday, April 14, 2026, at 9:00 a.m. ET. The Notice of Annual

More news about: BNY


Apr 02, 2026, 09:00 ET Burger King® Hiring up to 60,000 Team Members Across U.S. Restaurants

years, marked by modernized restaurants, improved operations, and initiatives that put Guests at the forefront. These efforts are driving more Guests to BK restaurants across the country, driving an immediate need for people with a passion for friendliness and hospitality to serve them.

More news about: Burger King


Mar 27, 2026, 09:00 ET UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis

https://www.ucb-usa.com/Innovation/Products/BIMZELX.US-BK-2600168Date of preparation: March 2026BIMZELX® is a registered trademark of the UCB Group of Companies.©2026 UCB,

More news about: UCB


Mar 27, 2026, 09:00 ET UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa

HEARD II): two 48 week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials. Lancet. 2024;403(10443):2504–19.US-BK-2600169Date of preparation: March 2026BIMZELX® is a registered trademark of the UCB Group of Companies.©2026 UCB, Inc., Smyrna,

More news about: UCB


Mar 26, 2026, 19:12 ET Axi 推出由 Kathy Lien 主持的 Podcast 節目《The Strategy Room》

悉尼2026年3月27日 /美通社/ -- 環球交易公司 Axi 今日宣佈,推出全新 Podcast 節目《The Strategy Room by Axi Select》,節目由著名貨幣策略師兼 BK Forex 董事總經理 Kathy Lien 主持。 此系列旨在讓交易員直接了解頂尖交易員及市場權威專家的策略佈局、思維脈絡及風險駕馭之道。

More news about: AxiTrader


Mar 26, 2026, 19:08 ET Axi lança podcast "The Strategy Room" apresentando por Kathy Lien

hoje o lançamento de The Strategy Room by Axi Select, uma nova série de podcasts apresentada pela renomada estrategista de moedas e diretora-gerente da BK Forex, Kathy Lien. A série foi projetada para fornecer aos traders acesso direto às estratégias, ao pensamento e às abordagens de gerenciamento de riscos

More news about: AxiTrader


Mar 26, 2026, 19:06 ET Axi presenta el podcast "The Strategy Room" presentado por Kathy Lien

de "The Strategy" Room por parte de Axi Select, una nueva serie de podcasts presentada por la reconocida estratega de divisas y directora general de BK Forex, Kathy Lien. La serie está diseñada para proporcionar a los operadores acceso directo a las estrategias, el pensamiento y los enfoques de gestión

More news about: AxiTrader


Mar 26, 2026, 11:30 ET HILCO GLOBAL ANNOUNCES TWO PARCELS TOTALING 4.3± AC AVAILABLE IN LOS ANGELES MSA VIA BANKRUPTCY SALE

use.The sale is subject to Bankruptcy Court Approval of the United States Bankruptcy Court for the Central District of California, Petition No. 8:25-bk-11912-SC, In re: 3000 E. Imperial, LLC. Bids must be received on or before the deadline of May 15, 2026, by 2:00 p.m. (PDT) and must be submitted

More news about: Hilco Trading, LLC


Mar 25, 2026, 18:31 ET Axi startet „The Strategy Room"-Podcast mit Host Kathy Lien

gab heute den Start von „The Strategy Room" by Axi Select bekannt, einer neuen Podcast-Reihe, die von der renommierten Währungsstrategin Kathy Lien, BK Forex Managing Director, moderiert wird. Die Reihe wurde entwickelt, um Tradern einen direkten Zugang zu den Strategien, Denkweisen und Risikomanagementansätzen

More news about: AxiTrader


Mar 25, 2026, 10:53 ET Axi lance le podcast « The Strategy Room » animé par Kathy Lien

le lancement de The Strategy Room by Axi Select, une nouvelle série de podcasts animée par la célèbre stratège des devises et directrice générale de BK Forex, Kathy Lien. La série est conçue pour fournir aux traders un accès direct aux stratégies, à la réflexion et aux approches de gestion des risques

More news about: AxiTrader


Mar 25, 2026, 09:23 ET Axi lanza el podcast "The Strategy Room" presentado por Kathy Lien

lanzamiento de The Strategy Room de Axi Select, una nueva serie de podcasts presentada por la reconocida estratega de divisas y directora general de BK Forex, Kathy Lien. La serie está diseñada para brindar a los operadores acceso directo a las estrategias, el pensamiento y los enfoques de gestión de

More news about: AxiTrader


Mar 25, 2026, 09:00 ET Axi Launches "The Strategy Room" Podcast Hosted by Kathy Lien

Global trading firm Axi today announced the launch of The Strategy Room by Axi Select, a new podcast series hosted by renowned currency strategist and BK Forex Managing Director Kathy Lien. The series is designed to provide traders with direct access to the strategies, thinking, and risk management approaches

More news about: AxiTrader


Mar 25, 2026, 09:00 ET Axi Launches "The Strategy Room" Podcast Hosted by Kathy Lien

Global trading firm Axi today announced the launch of The Strategy Room by Axi Select, a new podcast series hosted by renowned currency strategist and BK Forex Managing Director Kathy Lien. The series is designed to provide traders with direct access to the strategies, thinking, and risk management approaches

More news about: AxiTrader


Mar 23, 2026, 09:00 ET Genpact Named as One of the 2026 World's Most Ethical Companies® by Ethisphere for the Eighth Time

and human-validated environments, trust, accountability, and strong governance become essential to sustaining innovation at scale," said Balkrishan "BK" Kalra, President and Chief Executive Officer, Genpact. "This recognition reflects our long‑standing commitment to embedding integrity into our culture

More news about: Genpact


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la presentación regulatoria complementaria de MINJUVI® (tafasitamab) para linfoma folicular en Argentina y México

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la aprobación de una indicación adicional para MINJUVI® (tafasitamab) en Brasil

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 12, 2026, 23:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Mar 12, 2026, 23:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Mar 11, 2026, 11:18 ET RiseLink Redefines Edge AI with the BK7259 "Powerhouse" and R2 Unified AI Developer Platform at Embedded World 2026

connectivity with a 20-year legacy in semiconductor innovation, today announced the launch of its BK7259 Edge AI powerhouse at Embedded World 2026. As the centerpiece of the new R2 Unified AI Developer Platform, the BK7259 is designed to move intelligence from the cloud directly onto hardware, enabling a

More news about: Riselink


Mar 11, 2026, 07:00 ET BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50

https://www.ucb-usa.com/Innovation/Products/BIMZELX. Last accessed: March 2026.  GL-BK-2600024Date of preparation: March 2026© UCB Biopharma SRL, 2026. All rights reserved.

More news about: UCB


Mar 09, 2026, 12:00 ET Bloomberg Tax Showcases Industry-Leading AI-Powered Tools at TEI Midyear 2026

https://aboutbtax.com/bk2Y.About Bloomberg Tax Bloomberg Tax delivers a comprehensive suite of solutions designed to help tax and accounting

More news about: Bloomberg Tax


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.